Infrequent mutations of p16(INK4A) and p15(INK4B) genes in human pituitary adenomas

European Journal of Endocrinology

Volumn 136, Issue 1, 1997, Pages 74-80

  Yoshimoto, Katsuhiko ^a   Tanaka, Chisato ^a   Yamada, Shozo ^b   Kimura, Takehiko ^a   Iwahana, Hiroyuki ^a   Sano, Toshiaki ^a   Itakura, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; PROTEIN P16; CARRIER PROTEIN; CDKN2B PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MICROSATELLITE DNA; PRIMER DNA; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 9P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE MUTATION; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOPHYSIS; HYPOPHYSIS ADENOMA; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; ADENOMA; GENETIC POLYMORPHISM; GENETICS; HYPOPHYSIS TUMOR; LEUKOCYTE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE;

ADENOMA; ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; FEMALE; HUMANS; LEUKOCYTES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PITUITARY NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0030614560     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1360074     Document Type: Article

References (36)

1. Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H et al. Two G protein oncogenes in human endocrine tumors. Science 1990 249 655-659.
2. Yoshimoto K, Iwahana H, Fukuda A, Sano T & Itakura M. Rare mutations of the Gs alpha subunit in human endocrine tumors: Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Cancer 1993 72 1386-1393.
3. Yoshimoto K, Iwahana H, Fukuda A, Katsuragi K, Kinoshita M, Sano T et al. Ras mutations in endocrine tumors: Mutation detection by polymerase chain reaction-single strand conformation polymorphism. Japanese Journal of Cancer Research 1992 83 1057-1062.
4. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S & Itakura M. Role of p53 mutations in endocrine tumorigenesis: Mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Research 1992 52 5061-5064.
5. Cryns VL, Alexander JM, Klibanski A & Arnold A. The retinoblastoma gene in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism 1994 77 644-646.
6. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG & Black PM. Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. Journal of Clinical Endacrinology and Metabolism 1994 78 922-927.
7. Woloshak M, Roberts JL & Post KD. Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer 1994 74 693-696.
8. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF & Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Research 1995 55 1613-1616.
9. Boggild MD, Jenkinsin S, Pistorello M, Boscaro M, Scanarini M, McTernan P et al. Molecular genetic studies of sporadic pituitary tumors. Journal of Clinical Endocrinolagy and Metabolism 1994 78 387-392.
10. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 264 436-440.
11. Serrano M, Hannon GJ & Beach D. A new regulatory motif in cellcycle control causing specific inhibition of cyclin D/CDK4. Nature 1994 366 704-707.
12. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994 371 257-261.
13. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A et al Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genetics 1995 11 210-212.
14. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics 1994 8 22-26.
15. Mori T, Miura K. Takahisa A, Nishihara T, Mori S & Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Research 1994 54 3396-3397.
16. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Symour AB et al Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics 1994 8 27-32.
17. ink4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Research 1995 55 1448-1451.
18. ink4B/MTS2 genes in biliary tract cancers. Cancer Research 1995 55 2756-2760.
19. Ueki K, Ono Y, Hensen JW, Efird JT, von Deimling A & Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Research 1996 56 150-153.
20. ink4 protein is restricted to the subset of lung cancer lines that retains wild type RB. Oncogene 1994 9 3375-3378.
21. INK4A inactivation in non-small lung cancer cell lines. Cancer Research 1995 55 6200-6209.
22. Nakagawa K, Conrad NK, Williams JP, Johnson BE & Kelly MJ. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Oncogene 1995 11 1843-1851.
23. ink4 protein is restricted to the subset of lung cancer lines that retains wild type RB. Oncogene 1994 9 3375-3378.
24. ink4/MTS1 tumour suppressor gene product. EMBO Journal 1995 14 503-511.
25. Sano T, Ohshima T & Yamada S. Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas. Pathology Research and Practice 1991 187 530-533.
26. Hardy J & Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. In Advances in Neurology, pp 261-274. Eds RA Thompson & JR Gree. New York: Raven Press, 1976.
27. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P et al. The 1993-94 Généthon human genetic linkage map. Nature Genetics 1994 7 246-339.
28. Shintani Y, Yoshimoto K, Horie H, Sano T, Kanesaki Y, Hosoi E et al. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: Clinical and genetic features. Endocrine Journal 1995 42 331-340.
29. Walker DG, Duan W, Kaye AH & Lavin MF. Homozygous deletions of the MTS1 gene are rare in non-astrocytic brain tumors. Biochemical and Biophysical Research Communications 1995 211 404-409.
30. Yang R, Combart AF, Serrano M & Koeffler HP. Mutational effects on the tumor suppressor protein. Cancer Research 1995 55 2503-2506.
31. Holland EA, Beaton SC, Becker TM, Grulet OMC, Peters BA, Rizos H et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 1995 11 2289-2294.
32. Suzuki H, Zhou X, Yin J, Lei J, Jiang HY, Suzuki Y et al. Intragenic mutations of CDKN2B and CDKN2A in primary esophageal cancers. Human Molecular Genetics 1995 4 1883-1887.
33. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus J, Tavtigian SV. Cannon-Albright L et al. Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene 1995 11 987-991.
34. INK4A in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Research 1995 55 2892-2895.
35. Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC & Devereux TR. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Clinical Cancer Research 1995 1 687-690.
36. INK4A/MTS1 in human cancers. Nature Medicine 1995 1 686-692.